Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Finland

European Innovation Council · Finished

PREVENTDIABETES The world’s first needle-free continuous glucose monitor to prevent and manage diabetes at scale

Coordinator
Glucomodicum Oy, Finland
Runs
1 February 2022 to 31 January 2024
Status
Finished
EU funding
€2.5m
Total cost
€6.6m
Partners
1 organisations in 1 countries
Type
European Innovation Council
Grant agreement
190145869

What the project is doing

In the project's own words, from its summary on CORDIS.

Diabetes is one of the biggest health concerns globally: 6% of the world’s population already lives with diabetes, and another 35% is at a high risk of developing it. Proper management of diabetes starts with consistent and accurate monitoring of glucose levels. Yet, most diagnosed diabetics do not monitor their blood sugar as often as prescribed, because it is painful and inconvenient to do so. This is clear evidence that the €16+ billion glucose monitors industry needs a change – the current methods are not good enough.

We have invented, patented and productized a new technology category for extracting and analysing blood sugar levels in a completely non-invasive way. We are applying for the EIC blended finance to further miniaturise, optimise, and clinically prove this technology on a wider scale. The financing will turn our break-through scientific discovery into an end user device that can potentially impact over 2 billion people by helping them prevent diabetes onset altogether.

Topics

Who is involved

OrganisationCityCountryRole
Glucomodicum OyHelsinkiFinlandCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI